Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)Francisco Hernández‐Bernal, Verena L. Muzio‐González, Maria C. Ricardo-Cobas et al.|EClinicalMedicine|2022Cited by 69
Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort studyPedro I. Más-Bermejo, Marta Ayala‐Ávila, Félix O. Dickinson-Meneses et al.|The Lancet Regional Health - Americas|2022Cited by 35
Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective EffectsJorge Berlanga‐Acosta, Gerardo Guillén, Angel Abreu-Cruz et al.|Clinical Medicine Insights Cardiology|2017Cited by 24
Cuban Abdala Vaccine: Effectiveness in Preventing Severe Disease and Death from COVID-19 in Havana, Cuba; a Cohort StudyPedro Inocencio Más-Bermejo, Marta Ayala‐Ávila, Felix Orlando Dickinson-Meneses et al.|SSRN Electronic Journal|2022Cited by 23
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteersAnia Cabrales, Luis Javier González, Jeovanis Gil et al.|European Journal of Pharmaceutical Sciences|2012Cited by 15